Clinical Trial Update: Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Catheterization [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the impact of ACE inhibitors on contrast-induced nephropathy in patients undergoing cardiac catheterization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy
• Kidney Failure
• Kidney Injury

Drugs mentioned

• Angiotensin-converting enzyme inhibitors

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Kidney Failure | Phase 2 | Status: COMPLETED